340B Unscripted
Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!
Podcast Description
Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!
Episodes

27 minutes ago
Ep 96 | 340B Coalition Summer Conference Recap
27 minutes ago
27 minutes ago
39 min
In this episode, Greg and Rob recap highlights from this year's 340B Coalition Summer Conference in Washington, D.C.
Comments or questions? Email us at 340BUnscripted@spendmend.com

Jul 12, 2026
Ep 95 | 340B in 2026 – Midyear Review
Jul 12, 2026
Jul 12, 2026
1hr 7 min
In this episode, Greg and Rob are joined by Ted Slafsky and Will Newton of 340B Report. They recap major developments in the first half of 2026 that have impacted the 340B community. They’ll discuss recent Congressional activity, including a newly introduced 340B Program reform bill (SECURE 340B Act), trends in federal administrative agency policies from HRSA and CMS, and the evolution of various manufacturer actions within the 340B Program.
In the intro, they discuss recent HRSA audit finding trends and highlight key provisions in the CMS 2027 OPPS proposed rule, including anticipated Medicare Part B reimbursement reductions for 340B hospitals.
Use “SPENDMEND25” to get a 25% discount on a subscription to 340B Report: https://340breport.com/subscribe/
Going to the 340B Coalition Summer Meeting? Come see us at booth #418.

Jun 29, 2026
Jun 29, 2026
57 min
In this episode, Greg and Rob are joined by returning guest, healthcare attorney Emily Cook. They discuss a recent court ruling (Premier v HHS) that vacated HRSA’s 2013 GPO Prohibition policy notice that addresses compliance with inventory replenishment models, covering insights into the court’s opinion, what it means in terms of potential process changes for covered entities, and compliance considerations given that GPO Prohibition is still a statutory requirement for hospital eligibility in the 340B Program. They’ll also touch on thoughts related to the process of reporting 340B pricing access issues to HRSA based on manufacturer actions.
Premier v. HHS court opinion: https://law.justia.com/cases/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/27447…
340B Price Unavailability – How to Report to HRSA: 340B Price Unavailability - How to Report to HRSA | HRSA

Jun 15, 2026
Ep 93 | 340B Patient Definition
Jun 15, 2026
Jun 15, 2026
1hr 9 min
Rob and Greg are joined by healthcare attorney Mark Ogunsusi to discuss 340B patient definition, including the 1996 HRSA guidance, key regulatory developments over the years, and the impact that recent litigation might have on enforcement of this standard.

May 18, 2026
Ep 92 | Latest 340B Updates
May 18, 2026
May 18, 2026
23 min
In this week’s episode, Greg and Rob discuss developments across the 340B community, including new manufacturer claims level data submission policies and ongoing discussion in Congress on 340B Program reform.
Questions or comments? Email us at 340BUnscripted@spendmend.com!

May 4, 2026
Ep 91 | More 340B Updates
May 4, 2026
May 4, 2026
47 min
In this episode, Greg and Rob catch up on more recent developments across the 340B community. They discuss recent Congressional activity where 340B has been a focus, a shift in court rulings related to state contract pharmacy laws, and they catch up on recent litigation over 340B child site eligibility timing, GPO Prohibition policies, and patient definition. They round out the discussion by recapping developments with manufacturer contract pharmacy restrictions and claim-level data submission policies.
Email us questions at 340BUnscripted@spendmend.com

Apr 20, 2026
Ep 90 | 340B Updates
Apr 20, 2026
Apr 20, 2026
42 min
In this episode, Greg and Rob catch up on various developments happening in the 340B community. Topics discussed include the proliferation of manufacturer claim submission requirements, notable court rulings and 340B-related lawsuits, and reactions to Congressional hearings that featured testimony related to 340B Program reform considerations.
Got questions? Email us at 340BUnscripted@spendmend.com!

Apr 6, 2026
Apr 6, 2026
51 min
In this episode, Greg and Rob discuss reports of 340B pricing removal from wholesaler accounts, which may be related to recent manufacturer claim submission requirement policies. They also catch up on some developments in state-level contract pharmacy laws, including Washington’s newly passed state law that incorporates contract pharmacy provisions, as well as reporting requirements for both providers and manufacturers.
As a bonus, Nick Gnadt joins at the end to share an update on a recent court ruling (Premier v HHS) in which a judge vacated the 2013 HRSA GPO Prohibition Policy Notice.
Premier, Inc. v HRSA DC District Court Ruling: https://cases.justia.com/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/274475/23…
Questions for us? Email us at 340BUnscripted@spendmend.com

Your Expert Hosts
We are bringing a new podcast to you called “340B Unscripted” where we dive into the complicated and sometimes contentious aspects of the 340B Program, as well as other hot topics in the pharmacy and healthcare space. Our goal with this podcast is to help inspire and educate pharmacy professionals so they may take full advantage of everything the 340B Program has to offer, and in so doing they can better serve patients.








